Vivanza Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Vivanza Biosciences has a total shareholder equity of ₹48.5M and total debt of ₹52.7M, which brings its debt-to-equity ratio to 108.7%. Its total assets and total liabilities are ₹286.4M and ₹238.0M respectively. Vivanza Biosciences's EBIT is ₹14.3M making its interest coverage ratio 3.4. It has cash and short-term investments of ₹1.8M.
Key information
108.7%
Debt to equity ratio
₹52.66m
Debt
Interest coverage ratio | 3.4x |
Cash | ₹1.81m |
Equity | ₹48.46m |
Total liabilities | ₹237.97m |
Total assets | ₹286.43m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530057's short term assets (₹256.4M) exceed its short term liabilities (₹221.1M).
Long Term Liabilities: 530057's short term assets (₹256.4M) exceed its long term liabilities (₹16.8M).
Debt to Equity History and Analysis
Debt Level: 530057's net debt to equity ratio (104.9%) is considered high.
Reducing Debt: 530057's debt to equity ratio has increased from 37.6% to 108.7% over the past 5 years.
Debt Coverage: 530057's debt is well covered by operating cash flow (86.1%).
Interest Coverage: 530057's interest payments on its debt are well covered by EBIT (3.4x coverage).